Rat and human cytomegalovirus ORF116 encodes a virion envelope glycoprotein required for infectivity.


Journal

Virology
ISSN: 1096-0341
Titre abrégé: Virology
Pays: United States
ID NLM: 0110674

Informations de publication

Date de publication:
05 2021
Historique:
received: 25 09 2020
revised: 22 12 2020
accepted: 23 12 2020
pubmed: 19 2 2021
medline: 29 12 2021
entrez: 18 2 2021
Statut: ppublish

Résumé

Herpesviruses encode multiple glycoproteins required for different stages of viral attachment, fusion, and envelopment. The protein encoded by the human cytomegalovirus (HCMV) open reading frame UL116 forms a stable complex with glycoprotein H that is incorporated into virions. However, the function of this complex remains unknown. Herein, we characterize R116, the rat CMV (RCMV) putative homolog of UL116. Two R116 transcripts were identified in fibroblasts with three proteins expressed with molecular weights of 42, 58, and 82 kDa. R116 is N-glycosylated, expressed with late viral gene kinetics, and is incorporated into the virion envelope. RCMV lacking R116 failed to result in productive infection of fibroblasts and siRNA knockdown of R116 substantially reduced RCMV infectivity. Complementation in trans of an R116-deficient virus restored ability of the virus to infect fibroblasts. Finally, UL116 knockdown also decreased HCMV infectivity indicating that R116 and UL116 both contribute to viral infectivity.

Identifiants

pubmed: 33601113
pii: S0042-6822(20)30261-0
doi: 10.1016/j.virol.2020.12.014
pmc: PMC8019331
mid: NIHMS1674192
pii:
doi:

Substances chimiques

RNA, Double-Stranded 0
Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-33

Subventions

Organisme : NIAID NIH HHS
ID : F31 AI145193
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116633
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI116633
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007472
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Nat Struct Mol Biol. 2010 Jul;17(7):882-8
pubmed: 20601960
J Virol. 2012 Nov;86(21):11833-44
pubmed: 22915808
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7043-7052
pubmed: 30894498
Am J Transplant. 2013 Aug;13(8):2119-29
pubmed: 23731368
J Virol. 2006 May;80(9):4591-600
pubmed: 16611919
J Virol. 2009 Aug;83(15):7678-89
pubmed: 19457993
Cell. 2018 Aug 23;174(5):1158-1171.e19
pubmed: 30057110
J Virol. 2007 Oct;81(19):10316-28
pubmed: 17626081
J Virol. 1997 Apr;71(4):3090-7
pubmed: 9060671
J Clin Invest. 2011 May;121(5):1673-80
pubmed: 21659716
J Virol. 2004 Oct;78(20):11187-97
pubmed: 15452238
J Virol. 2010 Oct;84(19):10026-37
pubmed: 20660204
Clin Infect Dis. 2011 Nov;53(10):969-76
pubmed: 21960711
J Virol. 2016 Dec 16;91(1):
pubmed: 27795411
J Virol. 2003 Feb;77(3):2182-94
pubmed: 12525653
J Virol. 2008 Jan;82(1):60-70
pubmed: 17942555
Transpl Int. 2006 Nov;19(11):893-900
pubmed: 17018124
J Virol. 2007 Apr;81(8):3816-26
pubmed: 17251289
J Virol. 1992 Mar;66(3):1761-4
pubmed: 1310777
J Virol. 2005 Jul;79(13):8361-73
pubmed: 15956581
Am J Transplant. 2019 Feb;19(2):573-584
pubmed: 30431703
Virology. 2013 Jan 20;435(2):239-49
pubmed: 23089254
Nature. 2008 Sep 18;455(7211):391-5
pubmed: 18701889
Microbiol Mol Biol Rev. 2016 Jun 15;80(3):663-77
pubmed: 27307580
J Virol. 2008 Dec;82(23):11837-50
pubmed: 18815310
Nat Microbiol. 2016 Jun 06;1(8):16082
pubmed: 27573107
Sci Immunol. 2017 Jun 30;2(12):
pubmed: 28783665
J Virol. 2010 Jan;84(2):1005-13
pubmed: 19889756
PLoS Pathog. 2013;9(7):e1003463
pubmed: 23853586
J Gen Virol. 2005 Feb;86(Pt 2):275-284
pubmed: 15659746
J Virol. 2004 Sep;78(18):10023-33
pubmed: 15331735
J Virol. 2004 Oct;78(20):10960-6
pubmed: 15452216
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8209-14
pubmed: 24843144
J Virol. 2015 Sep;89(17):8999-9009
pubmed: 26085146
Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15470-5
pubmed: 15494436
Vaccine. 2007 Apr 30;25(17):3319-27
pubmed: 17287056
Nature. 2003 Jul 24;424(6947):456-61
pubmed: 12879076
Viruses. 2018 Dec 11;10(12):
pubmed: 30544948
J Virol. 2007 May;81(10):5212-24
pubmed: 17229708
mBio. 2013 Jun 04;4(3):e00332-13
pubmed: 23736286
J Virol. 2016 Apr 29;90(10):4926-38
pubmed: 26937030
J Gen Virol. 2006 Sep;87(Pt 9):2451-2460
pubmed: 16894182
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4471-6
pubmed: 25831500
Vaccines (Basel). 2017 Oct 31;5(4):
pubmed: 29088098
Am J Transplant. 2008 Feb;8(2):277-87
pubmed: 18093265
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14118-23
pubmed: 18768787
Transplantation. 2016 Mar;100 Suppl 3:S5-10
pubmed: 26900992
J Virol. 2011 Nov;85(22):11638-45
pubmed: 21880752
PLoS Pathog. 2017 Apr 12;13(4):e1006281
pubmed: 28403202
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1767-72
pubmed: 25624487
J Virol. 2005 Oct;79(19):12408-15
pubmed: 16160168
J Virol. 1998 Oct;72(10):8191-7
pubmed: 9733861

Auteurs

Philippe Gatault (P)

Renal Transplant Unit, 10 Boulevard Tonnellé, University Hospital of Tours, France.

Iris K A Jones (IKA)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

Christine Meyer (C)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

Craig Kreklywich (C)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

Timothy Alexander (T)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

Patricia P Smith (PP)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

Michael Denton (M)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

Josh Powell (J)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA.

Susan L Orloff (SL)

Department of Surgery, Oregon Health & Science University, Portland, OR, 97239, USA.

Daniel N Streblow (DN)

Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Electronic address: streblow@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH